Beta Drugs IPO vs Kaarya Facilities IPO

Comparison between Beta Drugs IPO and Kaarya Facilities IPO.

IPO Details

Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Kaarya Facilities IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Kaarya Facilities IPO is up to ₹6.07 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Kaarya Facilities IPO is ₹40.00 per share.

 Beta Drugs IPOKaarya Facilities IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹85.00 per share₹40.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares3000 shares
Fresh Issue Size21,66,400 shares15,18,000 shares
Fresh Issue Size (Amount)up to ₹18.41 Crup to ₹6.07 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total21,66,400 shares15,18,000 shares
Issue Size Total (Amount)up to ₹18.41 Crup to ₹6.07 Cr

IPO Timetable

Beta Drugs IPO opens on Sep 29, 2017, while Kaarya Facilities IPO opens on Oct 12, 2017. The closing date of Beta Drugs IPO and Kaarya Facilities IPO is Oct 04, 2017, and Oct 17, 2017, respectively.

 Beta Drugs IPOKaarya Facilities IPO
Issue OpenSep 29, 2017Oct 12, 2017
Issue CloseOct 04, 2017Oct 17, 2017
Basis Of Allotment (Tentative)Oct 10, 2017Oct 24, 2017
Listing date (Tentative)Oct 12, 2017Oct 27, 2017

Financials & KPIs

Beta Drugs IPO P/E ratio is , as compared to Kaarya Facilities IPO P/E ratio of .

 Beta Drugs IPOKaarya Facilities IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5415.208.01
Total Income41.6826.390.26
Profit After Tax5.181.130.11
NET Worth7.382.201.07
Reserves and Surplus6.371.190.06
Total Borrowing7.527.754.37
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Jul 201731 Mar 201731 Mar 201631 Mar 2015
Assets7.826.625.534.73
Total Income2.8810.678.418.08
Profit After Tax0.260.660.190.15
NET Worth3.792.001.431.24
Reserves and Surplus0.751.891.321.14
Total Borrowing2.292.763.072.20
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.78%84.24%
Promoter Shareholding (Post-Issue)68.89%55.44%
Market Cap₹73.52 Cr.₹18.70 Cr.

Shares Offered

In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Kaarya Facilities IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in Kaarya Facilities IPO.

 Beta Drugs IPOKaarya Facilities IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,29,600 shares81,000 shares
QIB0 shares0 shares
NII10,83,200 shares7,59,000 shares
RII10,83,200 shares7,59,000 shares
Employee0 shares0 shares
Total21,66,400 shares15,18,000 shares

Bids Received (Subscription)

Beta Drugs IPO subscribed 18.97x in total, whereas Kaarya Facilities IPO subscribed 18.90x.

 Beta Drugs IPOKaarya Facilities IPO
NII (times)29.93x14.97x
RII (times)8.00x22.83x
Total (times)18.97x18.90x

Compare with others

Compare:

Beta Drugs IPO Vs Kaarya Facilities IPO